pharmaceutical compounds that act on the central nervous system to treat neurodegenerative diseases and conditions such as memory deficits associated with Alzheimer's disease, impairment associated with the dementia of aging, stroke, and the neurological aspects of AIDS, as well as spinal cord injuries, expressly excluding pharmaceuticals for the treatment of amyotrophic lateral sclerosis, multiple sclerois and/or peripheral neuropathy